IFARA sat down with Bruce Brew, Serena Spudich and Scott Letendre to talk about the HIV community's resurgent interest in neurology and the impact HIV itself might have on neurocognitive impairment. Issues discussed included the move from researching dementia, which is less common now, to studying milder forms of neurocognitive impairment, including depression; the potential neurological toxicity of some antiretrovirals; how starting treatment early may reduce inflammation in the brain and prevent neural injury; what can be learned from studies on Alzheimer's and multiple sclerosis about brain involvement in these diseases that may be applicable to HIV research; and the impact of neurological research on searching for a cure for HIV.
Watch the video to learn more:
About the panelists:
Bruce Brew, M.B.B.S. (M.D.), F.R.A.C.P., Department of Neurology, St. Vincent's Hospital, Sidney, Australia
Serena Spudich, M.D., M.A., associate professor of neurology, Yale School of Medicine, New Haven, Connecticut
Scott Letendre, M.D., professor of medicine, University of California-San Diego, San Diego, California
The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.